Justin J.  Noznesky net worth and biography

Justin Noznesky Biography and Net Worth

Insider of AtriCure
Justin J. Noznesky has served as our Chief Marketing and Strategy Officer since March 2021, having previously served as our Senior Vice President, Marketing and Business Development since March 2016, as our Vice President, Marketing and Business Development since May 2014 and as our Vice President, Corporate Development from January 2014 to May 2014. From 2004 to 2013, Mr. Noznesky held progressive financial and business development positions at Vital Images, Inc., a subsidiary of Toshiba Medical Systems Corporation, including Vice President, Marketing and Business Development. Prior to working for Vital Images, Mr. Noznesky worked at UnitedHealth Group in Corporate Finance and at Arthur Andersen LLP as a senior auditor. Mr. Noznesky received his B.A. from Bethel University.

What is Justin J. Noznesky's net worth?

The estimated net worth of Justin J. Noznesky is at least $2.14 million as of May 1st, 2024. Mr. Noznesky owns 71,284 shares of AtriCure stock worth more than $2,142,084 as of December 19th. This net worth approximation does not reflect any other investments that Mr. Noznesky may own. Additionally, Mr. Noznesky receives a salary of $644,730.00 as Insider at AtriCure. Learn More about Justin J. Noznesky's net worth.

How old is Justin J. Noznesky?

Mr. Noznesky is currently 46 years old. There are 6 older executives and no younger executives at AtriCure. The oldest executive at AtriCure is Mr. Douglas J. Seith, Chief Operating Officer, who is 58 years old. Learn More on Justin J. Noznesky's age.

What is Justin J. Noznesky's salary?

As the Insider of AtriCure, Inc., Mr. Noznesky earns $644,730.00 per year. There are 6 executives that earn more than Mr. Noznesky. The highest earning executive at AtriCure is Mr. Michael H. Carrel, CEO, President & Director, who commands a salary of $2,010,000.00 per year. Learn More on Justin J. Noznesky's salary.

How do I contact Justin J. Noznesky?

The corporate mailing address for Mr. Noznesky and other AtriCure executives is 7555 INNOVATION WAY, MASON OH, 45040. AtriCure can also be reached via phone at (513) 755-4100 and via email at lynn@gilmartinir.com. Learn More on Justin J. Noznesky's contact information.

Has Justin J. Noznesky been buying or selling shares of AtriCure?

Justin J. Noznesky has not been actively trading shares of AtriCure over the course of the past ninety days. Most recently, Justin J. Noznesky sold 1,500 shares of the business's stock in a transaction on Wednesday, May 1st. The shares were sold at an average price of $24.09, for a transaction totalling $36,135.00. Following the completion of the sale, the insider now directly owns 71,284 shares of the company's stock, valued at $1,717,231.56. Learn More on Justin J. Noznesky's trading history.

Who are AtriCure's active insiders?

AtriCure's insider roster includes Tonya Austin (Insider), Mark Collar (Director), Vinayak Doraiswamy (Insider), Scott Drake (Director), Regina Groves (Director), David Grumhaus, Jr. (Portfolio Manager), Justin Noznesky (Insider), Salvatore Privitera (Insider), Douglas Seith (COO), Sven Wehrwein (Director), and Angela Wirick (CFO). Learn More on AtriCure's active insiders.

Are insiders buying or selling shares of AtriCure?

During the last year, AtriCure insiders bought shares 1 times. They purchased a total of 5,000 shares worth more than $111,250.00. During the last year, insiders at the medical device company sold shares 6 times. They sold a total of 18,116 shares worth more than $589,176.76. The most recent insider tranaction occured on August, 15th when Director Maggie Yuen sold 3,500 shares worth more than $84,245.00. Insiders at AtriCure own 3.2% of the company. Learn More about insider trades at AtriCure.

Information on this page was last updated on 8/15/2024.

Justin J. Noznesky Insider Trading History at AtriCure

See Full Table

Justin J. Noznesky Buying and Selling Activity at AtriCure

This chart shows Justin J Noznesky's buying and selling at AtriCure by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2021202220232024$0bought$0soldQ4Q1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4-$50k$0$50kTotal Insider BuyingTotal Insider Selling

AtriCure Company Overview

AtriCure logo
AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporarily blocking pain by ablating peripheral nerves to medical centers in the United States, Europe, the Asia-Pacific, and internationally. The company offers Isolator Synergy Clamps, single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation, and ablate cardiac tissue with the same device; and the Coolrail device, which enables users to make longer linear lines of ablation. It also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Systems, a single-use disposable device used for the treatment of symptomatic, drug-refractory, and long-standing persistent atrial fibrillation; cryoSPHERE probe, which provides temporary pain relief by applying cryothermic energy to targeted intercoastal peripheral nerves in the ribcage; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure. In addition, the company sells Lumitip dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; Glidepath guides for placement of clamps; Subtle Cannula's to support access for EPi-Sense catheters; and various reusable cardiac surgery instruments. It markets and sells its products through independent distributors and direct sales personnel. The company was incorporated in 2000 and is headquartered in Mason, Ohio.
Read More

Today's Range

Now: $30.05
Low: $29.92
High: $30.60

50 Day Range

MA: $33.17
Low: $27.05
High: $38.20

2 Week Range

Now: $30.05
Low: $18.94
High: $39.04

Volume

460,245 shs

Average Volume

695,025 shs

Market Capitalization

$1.47 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.4